[Alpha 1-acid glycoprotein and carbamazepine].
作者信息
Bruguerolle B, Bussière H, Jadot G
出版信息
Rev Neurol (Paris). 1983;139(11):679-80.
PMID:6677980
Abstract
Levels of alpha 1-acid glycoprotein (alpha 1-AGP) were determined in 40 epileptic patients who had been also treated with carbamazepine (CBZ) and, in some patients, phenobarbital (PB) for at least 3 months. alpha 1-AGP levels were also determined in 28 controls. CBZ dit not alter blood levels of alpha 1-AGP while CBZ-PB decreased them. Such results are at variance with recent studies which suggested an increase of alpha 1-AGP in epileptic patients treated either with phenytoin or phenytoin + PB, or + CBZ, or + primidone.
摘要
相似文献
1
[Alpha 1-acid glycoprotein and carbamazepine].
Rev Neurol (Paris). 1983;139(11):679-80.
2
[Clinicopharmacologic study of blood carbamazepine levels in a group of epileptic patients].
Riv Neurol. 1980 Jul-Aug;50(4):241-52.
3
4
5
Together, phenobarbital and carbamazepine lower the alpha 1-acid glycoprotein concentration in plasma of epileptic patients.
Clin Chem. 1984 Apr;30(4):590-1.
6
Evaluation of therapeutic drug monitoring of antiepileptic drugs.
Int J Clin Pharmacol Ther. 2003 Mar;41(3):126-31.
7
[Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
Rev Invest Clin. 2005 Jul-Aug;57(4):522-31.
8
PB:PRM ratio in patients with epilepsy treated with primidone.
Int J Clin Pharmacol Res. 1983;3(3):185-93.
9
[Primidone kinetics and analysis of its interactions with the major antiepileptic drugs].
Riv Neurol. 1983 Mar-Apr;53(2):81-93.
10
[The use of phenobarbital and carbamazepine (finlepsin) in children with epilepsy and cerebral spastic palsy with epileptic syndrome].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1990;90(8):25-7.
Zotero 插件